Details of the Drug Formulations

General Information of Drug (ID: DMUPFLI)

• Drug Name: Deutetrabenazine Drug Info
• Synonyms: Dutetrabenazine; Austedo; SD809; SD-809; SD 809; 1392826-25-3; Deutetrabenazine [USAN:INN]

Indication

Disease Entry	ICD 11	Status	REF
Huntington disease	8A01.10	Approved	[1]
Tardive dyskinesia	8A02.10	Approved	[2]

• Cross-matching ID:
  PubChem CID: 73437646
  CAS Number: 1392826-25-3
  TTD ID: D0E7ZU
  VARIDT ID: DR01127
  INTEDE ID: DR0445
  ACDINA ID: D00184

Full List of Drug Formulations Containing This Drug

Deutetrabenazine 12 mg tablet

Company	Formulation ID	FDA Description
Teva Neuroscience	F05457	Butylated hydroxytoluene; Butyl alcohol; Fd&c blue no. 2; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polysorbate 80; Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified; Shellac

Deutetrabenazine 6 mg tablet

Company	Formulation ID	FDA Description
Teva Neuroscience	F05458	Butylated hydroxytoluene; Fd&c red no. 40; Butyl alcohol; Fd&c blue no. 2; Magnesium stearate; Mannitol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polysorbate 80; Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified; Shellac

Deutetrabenazine 9 mg tablet

Company	Formulation ID	FDA Description
Teva Neuroscience	F05459	Butylated hydroxytoluene; Butyl alcohol; Fd&c blue no. 2; Magnesium stearate; Mannitol; Ammonia; Butylated hydroxyanisole; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Polysorbate 80; Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Povidone, unspecified; Shellac

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018
• [2] 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.